Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.27 - $11.9 $47 - $2,082
175 Added 3500.0%
180 $0
Q1 2022

May 16, 2022

SELL
$0.93 - $1.29 $28,963 - $40,175
-31,144 Reduced 99.98%
5 $0
Q4 2021

Feb 08, 2022

SELL
$1.14 - $1.58 $974 - $1,350
-855 Reduced 2.67%
31,149 $35,000
Q3 2021

Nov 15, 2021

BUY
$1.39 - $2.1 $43,383 - $65,543
31,211 Added 3935.81%
32,004 $49,000
Q2 2021

Sep 13, 2021

BUY
$1.56 - $2.26 $1,237 - $1,792
793 New
793 $2,000

About Hepion Pharmaceuticals, Inc.


  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $51.8M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.